Stem Cells Spin S.A. (WSE:SCS)
Poland · Delayed Price · Currency is PLN 0.4680
-0.0020 (-0.43%)
At close: Aug 25, 2026
Stem Cells Spin Revenue
Stem Cells Spin had revenue of 7.38K PLN in the quarter ending March 31, 2026, a decrease of -7.02%. This brings the company's revenue in the last twelve months to 65.18K, up 12.61% year-over-year. In the year 2025, Stem Cells Spin had annual revenue of 65.74K with 27.65% growth.
Revenue (ttm)
65.18K
Revenue Growth
+12.61%
P/S Ratio
330.86
Revenue / Employee
58.47K
Employees
1
Market Cap
19.35M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.74K | 14.24K | 27.65% |
| Dec 31, 2024 | 51.50K | -340.23K | -86.85% |
| Dec 31, 2023 | 391.73K | 143.37K | 57.73% |
| Dec 31, 2022 | 248.36K | -277.56K | -52.78% |
| Dec 31, 2021 | 525.92K | 257.60K | 96.00% |
| Dec 31, 2020 | 268.32K | -285.08K | -51.51% |
| Dec 31, 2019 | 553.40K | 4.14K | 0.75% |
| Dec 31, 2018 | 549.26K | -157.38K | -22.27% |
| Dec 31, 2017 | 706.64K | -324.31K | -31.46% |
| Dec 31, 2016 | 1.03M | -860.88K | -45.51% |
| Dec 31, 2015 | 1.89M | 1.28M | 207.41% |
| Dec 31, 2014 | 615.41K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 932.97M |
| Voxel | 583.14M |
| Sygnis | 11.61M |
| InventionMed | 2.90M |
| genXone | 2.48M |
| Pharmena | 1.61M |